Metabolic differences between primary and recurrent human brain tumors: A 1H NMR spectroscopic investigation

NMR in Biomedicine

Volumn 18, Issue 6, 2005, Pages 371-382

  Lehnhardt, Fritz Georg ^a   Bock, Christian ^a   Röhn, Gabriele ^b   Ernestus, Ralf Ingo ^b   Hoehn, Mathias ^a  

^a MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

1H NMR spectroscopy; Astrocytoma; Glioma; Human brain tumors; Recurrent tumors

Indexed keywords

BRAIN; MAGNETIC RESONANCE SPECTROSCOPY; METABOLISM; NUCLEAR MAGNETIC RESONANCE; TISSUE; TUMORS;

ASTROCYTOMA; GLIOMA; HIGH RESOLUTION NMR SPECTROSCOPY; HUMAN BRAIN TUMORS; RECURRENT TUMORS;

NEUROLOGY;

ALANINE; CHOLINE; CREATININE; GLUTAMINE; GLYCINE;

ADULT; ANAPLASTIC CARCINOMA; ARTICLE; ASTROCYTOMA; BRAIN METABOLISM; BRAIN TUMOR; CANCER GRADING; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALIGNANT TRANSFORMATION; MENINGIOMA; PRIORITY JOURNAL; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; RECURRENCE RISK; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SIGNAL DETECTION; SPECTROSCOPY; STATISTICAL SIGNIFICANCE; TUMOR RECURRENCE;

ADULT; ASTROCYTOMA; BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MENINGIOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROTONS; TUMOR MARKERS, BIOLOGICAL;

EID: 26244436659     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/nbm.968     Document Type: Article

References (47)

1. Negendank W. Studies of human tumors by MRS: a review. NMR Biomed. 1992; 5: 303-324.
2. Bruhn H, Frahm J, Gyngell ML, Merboldt KD, Hanicke W, Sauter R, Hamburger C. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors [see comments]. Radiology 1989; 172: 541-548.
3. Tedeschi G, Lundbom N, Raman R, Bonavita S, Duyn JH, Alger JR, Di C. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J. Neurosurg. 1997; 87: 516-524.
4. Vigneron D, Bollen A, McDermott M, Wald L, Day M, Moyher-Noworolski S, Henry R, Chang S, Berger M, Dillon W, Nelson S. Three-dimensional magnetic resonance spectroscopic imaging of histologically confirmed brain tumors. Magn. Reson. Imaging 2001; 19: 89-101.
5. 1H MR spectroscopy of brain tumours and masses. NMR Biomed. 2003; 16: 123-131.
6. Freeman JJ. Regulatory mechanisms of choline production. Life Sci. 1996; 58: 1921-1927.
7. 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed. 1991; 4: 47-52.
8. 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci. 1996; 58: 1929-1935.
9. Podo F. Tumour phospholipid metabolism. NMR Biomed. 1999; 12: 413-439.
10. 1H NMR spectroscopy in vivo and in vitro. J. Neurochem. 1994; 63: 1538-1543.
11. Shimizu H, Kumabe T, Shirane R, Yoshimoto T. Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. AJNR Am. J. Neuroradiol. 2000; 21: 659-665.
12. Gill SS, Thomas DG, Van Bruggen N, Gadian DG, Peden CJ, Bell JD, Cox IJ, Menon DK, Iles RA, Bryant DJ. Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies. J. Comput. Assist. Tomogr. 1990; 14: 497-504.
13. Negendank WG, Sauter R, Brown TR, Evelhoch JL, Falini A, Gotsis ED, Heerschap A, Kamada K, Lee BC, Mengeot MM, Moser E, Padavic-Shaller KA, Sanders JA, Spraggins TA, Stillman AE, Terwey B, Vogl TJ, Wicklow K, Zimmerman RA. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J. Neurosurg. 1996; 84: 449-458.
14. 1H MRS and in vitro multinuclear MR study of human brain tumors. Anticancer Res. 1996; 16: 2891-2899.
15. Kugel H, Heindel W, Ernestus RI, Bunke J, du Mesnil R, Friedmann G. Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. Radiology 1992; 183: 701-709.
16. 1H MRS spectra from brain tumours. NMR Biomed. 1998; 11: 177-191.
17. Klunk WE, Panchalingam K, Moossy J, McClure RJ, Pettegrew JW. N-Acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study. Neurology 1992; 42: 1578-1585.
18. Higuchi T, Graham SH, Fernandez EJ, Rooney WD, Gaspary HL, Weiner MW, Maudsley AA. Effects of severe global ischemia on N-acetylaspartate and other metabolites in the rat brain. Magn. Reson. Med. 1997; 37: 851-857.
19. Florian CL, Preece NE, Bhakoo KK, Williams SR, Noble MD. Cell type-specific fingerprinting of meningioma and meningeal cells by proton nuclear magnetic resonance spectroscopy. Cancer Res. 1995; 55: 420-427.
20. 1H NMR spectroscopy studies of extracts of human cerebral neoplasms. Magn. Reson. Med. 1992; 24: 123-136.
21. 1H NMR spectroscopy in vivo and in vitro. J. Comput. Assist. Tomogr. 1994; 18: 705-713.
22. Bruhn H, Michaelis T, Merboldt KD, Hanicke W, Gyngell ML, Hamburger C, Frahm J. On the interpretation of proton NMR spectra from brain tumours in vivo and in vitro. NMR Biomed. 1992; 5: 253-258.
23. 1H magnetic resonance spectroscopy of extracts of human epileptic neocortex and hippocampus. Neurology 1993; 43: 589-594.
24. 1H MRS of human brain tumor and normal glial cells. NMR Biomed. 1994; 7: 111-120.
25. 1H NMR markers of neuronal and glial disorders. NMR Biomed. 1989; 2: 196-200.
26. Kinoshita Y, Kajiwara H, Yokota A, Koga Y. Proton magnetic resonance spectroscopy of astrocytic tumors: an in vitro study. Neurol. Med.-Chir. (Tokyo) 1993; 33: 350-359.
27. 1H magnetic resonance spectroscopy and amino acid analysis. Clin. Cancer Res. 2000; 6: 3983-3993.
28. Laws ERJ, Taylor WF, Clifton MB, Okazaki H. Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J. Neurosurg. 1984; 61: 665-673.
29. Zülch KJ. Brain Tumors: Their Biology and Pathology. Zülch: Berlin, 1986.
30. Francavilla TL, Miletich RS, Di CG, Patronas NJ, Rizzoli HV, Wright DC. Positron emission tomography in the detection of malignant degeneration of low-grade gliomas. Neurosurgery 1989; 24: 1-5.
31. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol. 1993; 3: 255-268.
32. Remy C, Arus C, Ziegler A, Lai ES, Moreno A, Le Fur Y, Decorps M. In vivo, ex vivo and in vitro one- and two-dimensional nuclear magnetic resonance spectroscopy of an intracerebral glioma in rat brain: assignment of resonances. J. Neurochem. 1994; 62: 166-179.
33. 1H NMR spectroscopy for three types of human brain and nervous system tumours. NMR Biomed. 1995; 8: 253-264.
34. Preston-Martin S. Epidemiology of primary CNS neoplasms. Neurol. Clinics 1996; 14: 273-290.
35. Petroff OA, Spencer DD, Alger JR, Prichard JW. High-field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy. Neurology 1989; 39: 1197-1202.
36. Kinoshita Y, Yokota A. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. NMR Biomed. 1997; 10: 2-12.
37. 1H-magnetic resonance spectroscopy of pediatric posterior fossa tumors in vitro. J. Neurosurg. 1994; 81: 443-448.
38. 1H NMR spectroscopic studies of brain. Neurosci. Biobehav. Rev. 1989; 13: 23-31.
39. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 1993; 13: 981-989.
40. 1H MR spectroscopy. NMR Biomed. 1994; 7: 172-180.
41. 1H MRS analysis of human brain tumors. Anticancer Res. 1996; 16: 1559-1563.
42. 1H spectroscopy. Glutamate and glutamine; myo-inositol and related metabolites. NMR Biomed. 1991; 4: 59-63.
43. Leibfritz D, Brand A. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. J. Neurochem. 1993; 61: 5247.
44. Patel AJ, Hunt A. Concentration of free amino acids in primary cultures of neurones and astrocytes. J. Neurochem. 1985; 44: 1816-1821.
45. 1H NMR spectra of human brain in vivo. NMR Biomed. 1991; 4: 90-98.
46. Graves EE, Nelson SJ, Vigneron DB, Verhey L, McDermott M, Larson D, Chang S, Prados MD, Dillon WP. Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery [see comments]. AJNR Am. J. Neuroradiol. 2001; 22: 613-624.
47. 31P-MR spectroscopy of primary and recurrent human brain tumors in vitro: malignancy-characteristic profiles of water soluble and lipophilic spectral components. NMR Biomed. 2001; 14: 307-317.